Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
about
Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains.Characteristics and dynamics of bacterial populations during postantibiotic effect determined by flow cytometry.In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteriaEvaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.Different patterns of bacterial DNA synthesis during postantibiotic effectContinuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infectionsUse of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenemThe postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC.Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase.Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coliPostantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivoComparison of electronic and viability counting methods for determination of postantibiotic effect of oxacillin on Staphylococcus aureus.Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients.Delivering antibacterials to the lungs: considerations for optimizing outcomes.Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.Continuous infusion of beta-lactam antibioticsPopulation pharmacokinetics of imipenem in burn patients.Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.Continuous beta-lactam infusion in critically ill patients: the clinical evidenceInfluence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model.Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model.The use of carbapenems in the treatment of serious infections.Augmented renal clearance: implications for antibacterial dosing in the critically ill.Once-daily aminoglycoside therapyAntimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.Role of pharmacokinetics in the outcome of infections.Technical aspects and clinical correlations of the serum bactericidal test.Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP.In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.Pharmacodynamic effects of subinhibitory concentrations of imipenem on Pseudomonas aeruginosa in an in vitro dynamic model.Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration.Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.In vivo and in vitro study of several pharmacodynamic effects of meropenem.Influence on Enterobacter cloacae metabolism, cell-surface hydrophobicity and motility of suprainhibitory concentrations of carbapenems.Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans.
P2860
Q33594918-7BB95311-F012-46B1-961A-C8CEC052DFE7Q33695042-2EA2BE83-7491-4766-8C8D-BE67084A8E05Q33696946-4E4D8294-9439-4B40-94EB-BBE383CA3D09Q33770046-C0B264D8-A219-4CEB-A01F-BED3B9C94FC6Q35115294-D55C6CC3-8258-4043-8934-9FE8B0B46CC4Q35123123-A3D80C3C-3E88-4C2B-B669-5832771B6248Q35132306-B4A01807-1072-4C03-9AA2-FF3E6EE54FA9Q35137637-DD5C3A58-D2DB-41A1-9DC8-5E51FCB09900Q35139016-F96D35D6-ED44-42BF-8172-9363ACA9DF46Q35298021-70A0D743-7C50-433F-8F76-9D45F5BDD037Q35354562-FD436FA2-FCB6-4EA1-9612-33EE3B9D2505Q35364815-66D24B00-7BCC-4E48-8EA8-698F2A612BA4Q35541720-5814EDE7-FDA7-4BA4-978B-27ED155FD453Q35627814-565DF672-C383-42A5-82F5-6603672921DBQ35648690-A1E6A917-7983-4C7E-B77B-51F86269C70BQ35656806-CD35D173-C444-4ED0-A4C2-9AC183FB6661Q35688601-1F0710BC-57DE-4C74-BD60-DF13D6F3A151Q35809041-185FC459-E15B-4D55-8D20-A7088BB51A68Q35819487-73A92A2C-244B-4A33-89A8-9051F0B05B45Q36083619-1D490325-162A-4D8D-B093-213E38B6F5B1Q36329228-BBBCF71D-3557-4CE9-8DB6-1960FE57232EQ36505518-C10611AB-BD76-43F0-A95C-D744CE68F1D6Q36754206-0A5BCCFF-A5FE-4709-A632-17D429C6F45FQ36754960-FB0C2942-0D6B-4F6B-8E2B-4B625959F236Q37555757-E8ED4F30-E2C3-4BE9-9DD7-CEBD2DB0D32BQ37650115-A6519D56-F3A9-46B3-B964-94857FE17E16Q37730823-115E69D1-8890-47D4-B120-6E863A3814BBQ38117578-B9E46C96-74D9-4266-BC14-9FF7F136F9CDQ38664871-0062DA8D-FE20-43A1-842F-BCCDC4C5834DQ39639407-AA4C7140-D9B3-4AB1-BF91-BC0423970C74Q39731823-25C9F8FB-E8C9-4CFB-BB78-D501B663CB96Q39783290-758E8573-6819-462A-BF46-1CA32C848D7BQ39815200-6BB80AE8-8199-4AFF-A63B-58EBF5CAE4DBQ39833008-8A013ADF-13CB-41AA-BACB-8C9BB3EE4FFAQ39867146-9679D9CC-D2B1-4DF4-A46E-3DDFC81614A0Q39879629-603680C1-4E23-4EEF-B639-0B4E96361220Q40087367-E6563687-3822-4903-8FB5-3765259F2084Q43771580-04675B21-68EB-4C3A-89FB-1F1673A342B9Q43920262-2559A423-36FC-4173-8A93-6922D7654495Q44024994-9F8DB756-94ED-4CD0-8A5A-125630EA900E
P2860
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
@en
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
@nl
type
label
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
@en
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
@nl
prefLabel
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
@en
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
@nl
P2093
P2860
P356
P1476
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
@en
P2093
Bustamante CI
Drusano GL
Standiford HC
P2860
P304
P356
10.1128/AAC.26.5.678
P407
P577
1984-11-01T00:00:00Z